AbL Diagnostics SA (ABLD) — Capital Reinvestment Ratio
Latest as of June 2025:
0.84x
AbL Diagnostics SA (ABLD) has a Capital Reinvestment Ratio of 0.84x as of June 2025, meaning it reinvests 1% of its operating cash flow (€479.46K) in capital expenditures (€400.39K). See AbL Diagnostics SA (ABLD) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.84x
Capex / Operating Cash Flow
Operating Cash Flow
€479.46K
EUR
Capital Expenditures
€400.39K
EUR
Data as of
Jun 2025
Most recent filing
AbL Diagnostics SA Capital Reinvestment Ratio (2017–2025)
This chart tracks AbL Diagnostics SA's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for AbL Diagnostics SA (2017–2025)
Year-by-year Capital Reinvestment Ratio for AbL Diagnostics SA from 2017 to 2025. For live market cap and broader valuation context, see how much is AbL Diagnostics SA worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | €1.51 Million | €792.67K | ▼ -48.1% |
| 2023 | 1.01x | €926.43K | €938.50K | ▼ -87.3% |
| 2018 | 7.95x | €81.10K | €644.40K | ▲ +1658.8% |
| 2017 | 0.45x | €675.20K | €305.02K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow